Intriguingly, we found that anti-TNF-α treatment markedly decreased expression of neutrophil-derived MPO and calprotectin in inflamed mucosa from patients with IBD (Figures 3(a)–3(c)). This evidence concerns the gene MPO and inflammatory bowel disease.